NSE · KMCSHIL
KMC Speciality Hospitals (India) Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹311 Cr with net profit ₹47 Cr — a 15.03% net margin, versus 9.13% the period before.
Shareholding
As of 2026-06-30
- Promoter75%
- Public24.98%
- FII0.02%
- DII0%
88,487 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.13× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #25 of 85 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,27,048 Cr | 60.38 | 13.4 | 20.48% | 7.91% |
| Max Healthcare Institute Ltd. | ₹1,01,000 Cr | 67.47 | 9.4 | 13.42% | 16.73% |
| Manipal Health Enterpri Limited | ₹94,359 Cr | 100.61 | 5.74 | 10.59% | 7.81% |
| Fortis Healthcare Ltd. | ₹67,025 Cr | 62.83 | 6.77 | 10.53% | 11.02% |
| Aster DM Quality Care Ltd. | ₹66,652 Cr | 171.83 | 15.85 | 8.48% | 6.54% |
| Global Health Limited | ₹38,911 Cr | 67.98 | 9.82 | 14.05% | 11.88% |
| Narayana Hrudayalaya Ltd. | ₹38,199 Cr | 44.31 | 8.42 | 17.76% | 9% |
| Krishna Institute of Medical Sciences Ltd. | ₹32,296 Cr | 154.72 | 8.62 | 10.74% | 4.85% |
| Dr. Lal Path Labs Ltd. | ₹32,042 Cr | 56.97 | 12.77 | 20.13% | 18.75% |
| Poly Medicure Ltd. | ₹17,613 Cr | 55.04 | 5.67 | 10.37% | 15.77% |
| KMC Speciality Hospitals (India) Ltd.(this company) | ₹2,258 Cr | 40.49 | 10.73 | 22.21% | 16.85% |
AI analysis
AI-generated · google/gemini-2.5-flashKMC Speciality Hospitals (India) Ltd. is listed with a market capitalization of Rs 2189 Cr. The company's EPS stands at 2.87, with an ROE of 22.21% and ROCE of 24.22%.
Positives
- +Promoter holding is high at 75% as of June 30, 2026.
- +The company has no promoter share pledges.
- +Return on Capital Employed (ROCE) is healthy at 24.22%.
- +Net profit increased from Rs 12.78 Cr in Mar 2021 to Rs 30.38 Cr in Mar 2024.
- +Public shareholding is 24.98% as of June 30, 2026.
Negatives
- −Annual net profit decreased from Rs 30.38 Cr in Mar 2024 to Rs 21.43 Cr in Mar 2025.
- −Annual EPS decreased from 1.86 in Mar 2024 to 1.31 in Mar 2025.
- −The dividend yield is 0, indicating no dividends were paid.
Financial Performance
Annual revenue has shown growth, increasing from Rs 104.56 Cr in Mar 2021 to Rs 234.68 Cr in Mar 2025. Net profit also increased from Rs 12.78 Cr in Mar 2021 to Rs 30.38 Cr in Mar 2024, before declining to Rs 21.43 Cr in Mar 2025. Quarterly revenue has consistently grown over the last year, from Rs 61.36 Cr in Dec 2024 to Rs 82.25 Cr in Mar 2026.
Profitability & Returns
The company reported a profit margin of 15.29%. Return on Equity (ROE) is 22.21%, and Return on Capital Employed (ROCE) is 24.22%. Annual EPS decreased from 1.86 in Mar 2024 to 1.31 in Mar 2025.
Balance Sheet
The company has a debt-to-equity ratio of 0.56. The book value per share is Rs 12.9.
Ownership & Pledges
There are no promoter shares pledged.
Regulatory & Surveillance
No information regarding regulatory actions or surveillance measures is available for the company.
Data as of — price: 2026-09-11 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to KMC Speciality Hospitals (India) Ltd.share price & fundamentals